Mason Investment Advisory Services, Inc. Abbott Laboratories Transaction History

Mason Investment Advisory Services, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 07, 2024	SELL	$102.07 - $123.37 $606,295 - $732,817	-5,940 Closed	0 $0
Q1 2022 Aug 07, 2024	BUY	$114.02 - $139.04 $677,278 - $825,897	5,940 New	5,940 $703 Million
Q4 2021 Aug 06, 2024	SELL	$115.53 - $141.46 $143,257 - $175,410	-1,240 Reduced 17.27%	5,940 $836 Million
Q1 2021 Aug 06, 2024	BUY	$108.84 - $128.23 $781,471 - $920,691	7,180 New	7,180 $860 Million
Q1 2020 Aug 05, 2024	BUY	$62.82 - $91.86 $451,047 - $659,554	7,180 New	7,180 $567 Million
Q3 2019 Aug 02, 2024	SELL	$81.84 - $88.74 $148,375 - $160,885	-1,813 Reduced 20.16%	7,180 $601 Million
Q1 2019 Aug 02, 2024	BUY	$66.22 - $80.06 $595,516 - $719,979	8,993 New	8,993 $719 Million

3,161

1.33B

8.63M

7.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Mason Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Mason Investment Advisory Services, Inc. with notifications on news.